1.The Influence of Newly Introduced Nursing Care Insurance System on Community-Based Rehabilitation
Toshiyasu HANAOKA ; Kaoru KURIHARA ; Yasuko HINATA ; Michiko SATO ; Michiko KUBOTA ; Toshihide TORIYAMA ; Akira KANAI
Journal of the Japanese Association of Rural Medicine 2003;52(1):90-94
A follow up study was made on patients who were admitted into our hospital because of stroke or fracture of the neck of the thighbone before and after the Nursing Care Insurance Law was enforced. The study found that there was a salient tendency for the number of days the patients stayed in hospital to increase and for the rate of discharge from hospital to the patients home to decrease.
As the nursing care insurance system came to stay, one local government after another was pulling out the functional training work which had been conducted as one from of the rehabilitation projects. In place of municipalities, nursing care service contractors were taking on such health service work as home visits for rehabilitation, and outside visits for nursing and rehabilitation. In the future, it would be necessary to establish a network enouth to promote health and welfare services including the provision of medical and rehabilitation equipment and the repair of houses.
2.β-(1,3)-Glucan derived from Candida albicans induces inflammatory cytokines from macrophages and lamina propria mononuclear cells derived from patients with Crohn's disease.
Kiyoto MORI ; Makoto NAGANUMA ; Shinta MIZUNO ; Hiroaki SUZUKI ; Mina T. KITAZUME ; Katsuyoshi SHIMAMURA ; Sayako CHIBA ; Akira SUGITA ; Katsuyoshi MATSUOKA ; Tadakazu HISAMATSU ; Takanori KANAI
Intestinal Research 2018;16(3):384-392
BACKGROUND/AIMS: Recent research has highlighted the importance of interactions between commensal fungi and intestinal inflammation. However, there are few studies investigating whether commensal fungi contribute to inflammation in patients with Crohn's disease (CD). The aim of this study is to investigate reveal interactions between commensal fungi and host immune cells in CD. METHODS: CD14-positive monocytes were isolated from peripheral blood mononuclear cells from healthy human volunteers and then differentiated in the presence of macrophage colony-stimulating factor (M-CSF) (referred to as M-macrophages, M-Mϕs) or M-CSF and interferon-γ (IFN-γ) (referred to as M-gamma macrophages, Mγ-Mϕs). Cytokine production by these in vitro differentiated macrophages in response to β-(1,3)-glucan was analyzed by flow cytometry. Expression of Dectin-1 was examined using flow cytometry, western blotting, and quantitative reverse transcription-polymerase chain reaction. Cytokine production by in vitro differentiated macrophages in response to β-(1,3)-glucan was measured in the presence of an anti-Dectin-1 receptor antagonist, anti-Syr, or an anti-Fas-1 antibody. Cytokine production by lamina propria mononuclear cells (LPMCs) derived from CD patients in response to β-(1,3)-glucan was also analyzed. RESULTS: Mγ-Mϕs produced a large amount of tumor necrosis factor-α (TNF-α) and interleukin-6 in response to β-(1,3)-glucan. Dectin-1 expression was significantly higher in Mγ-Mϕs than in M-Mϕs. The increase in TNF-α production by Mγ-Mϕs stimulated with glucan was reversed by blocking Dectin-1, Syr or Fas-1. LPMCs derived from CD patients stimulated with β-(1,3)-glucan produced significantly higher amount of TNF-α than LPMCs derived from UC patients. CONCLUSIONS: These results suggest that commensal fungal microbiota may contribute to the pathogenesis of CD by inducing macrophages-derived pro-inflammatory cytokines.
Blotting, Western
;
Candida albicans*
;
Candida*
;
Crohn Disease*
;
Cytokines*
;
Flow Cytometry
;
Fungi
;
Healthy Volunteers
;
Humans
;
In Vitro Techniques
;
Inflammation
;
Interleukin-6
;
Macrophage Colony-Stimulating Factor
;
Macrophages*
;
Microbiota
;
Monocytes
;
Mucous Membrane*
;
Necrosis
;
Tumor Necrosis Factor-alpha
3.Effect of elemental diet combined with infliximab dose escalation in patients with Crohn's disease with loss of response to infliximab: CERISIER trial.
Tadakazu HISAMATSU ; Reiko KUNISAKI ; Shiro NAKAMURA ; Tomoyuki TSUJIKAWA ; Fumihito HIRAI ; Hiroshi NAKASE ; Kenji WATANABE ; Kaoru YOKOYAMA ; Masakazu NAGAHORI ; Takanori KANAI ; Makoto NAGANUMA ; Hirofumi MICHIMAE ; Akira ANDOH ; Akihiro YAMADA ; Tadashi YOKOYAMA ; Noriko KAMATA ; Shinji TANAKA ; Yasuo SUZUKI ; Toshifumi HIBI ; Mamoru WATANABE
Intestinal Research 2018;16(3):494-498
No abstract available.
Crohn Disease*
;
Food, Formulated*
;
Humans
;
Infliximab*